FDA Approves YAZ(R), The First Oral Contraceptive To Offer Drospirenone In A 24-Day, Active-Pill Regimen

... Berlex, Inc., a U.S. affiliate ofSchering AG, Germany (FSE: SCH; NYSE: SHR), announced today that the U.S. Foodand Drug Administration (FDA) has approved YAZ(R) (3 mg drospirenone/20 mcgethinyl estradiol), a new monophasic oral contraceptive (OC) and the firstpill to combine 20 mcg of ethinyl estradiol with the innovative progestindrospirenone (drsp)... click link for more info. ...